Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    50+ Branded Semaglutide Generics To Enter India As Diabetes Drug Patent Expires In March 2026

    2 hours ago

    Semaglutide patent in India expires in March 2026, enabling over 50 branded generic versions to enter the market, likely reducing treatment costs for diabetes and obesity patients.
    Click here to Read More
    Previous Article
    How Much Does It Cost To Live Alone In Goa? Techie Shares Rs 82,000 Expenses Breakdown
    Next Article
    Summer Heat And Heatwaves Can Trigger Nosebleeds: What You Must Know About First Aid And Long-Term Care

    Related Breaking News Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment